Compare Humana Inc (HUM) vs OneSpan Inc (OSPN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs OneSpan Inc — how do they compare? Humana Inc trades at $373.38 (market cap $46.31B), while OneSpan Inc trades at $16.29 (market cap $603.27M). The key difference: Humana Inc is far larger — about 76.8× OneSpan Inc's market cap, and OneSpan Inc pays the higher dividend (3.18%). Which is the better fit depends on your goals.
| HUM | OSPN | |
|---|---|---|
Market Cap | $46.31B | $603.27M |
Sector | Health | Technology |
52-Week High | $409.42 | $16.78 |
52-Week Low | $163.67 | $10.15 |
Enterprise Value | $53.67B | $572.35M |
Dividend Yield | 0.92% | 3.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
OneSpan (OSPN) trades at $16.78, up 3.33% today, with a bullish technical outlook and strong analyst support. The stock exhibits robust fundamentals, including a P/E of 9.25, net income margin of 27.76%, and consistent earnings beats in recent quarters. Recent news highlights Q2 2026 revenue growth and raised full-year guidance, reflecting positive business momentum.
The outlook is positive, driven by earnings strength and strategic initiatives, but risks include competitive pressures and potential margin compression. With a consensus price target of $17.00 and 67% buy ratings, Wall Street sees modest upside from current levels amid overall solid financial health.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About OneSpan Inc
OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →
